Susan S. Jick, DSc

Professor, Epidemiology
Susan Jick
Boston Collaborative Drug Surveillance Program
View full profile at BUMC


Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.


  • Boston University, MPH
  • Carleton College, BA
  • Boston University, DSc

Classes Taught

  • SPHEP748


  • Published on 5/29/2017

    Becker C, Jick SS, Meier CR. Selective Serotonin Reuptake Inhibitors and Cataract Risk: A Case-Control Analysis. Ophthalmology. 2017 May 29. PMID: 28571893.

    Read at: PubMed
  • Published on 5/2/2017

    Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of Incident Antidepressant-Treated Depression Associated with Use of 5a-Reductase Inhibitors Compared with Use of a-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink. Pharmacotherapy. 2017 May; 37(5):517-527. PMID: 28295443.

    Read at: PubMed
  • Published on 5/1/2017

    Becker C, Jick SS, Meier CR, Bodmer M. Metformin and the risk of renal cell carcinoma: a case-control analysis. Eur J Cancer Prev. 2017 May; 26(3):257-262. PMID: 26945286.

    Read at: PubMed
  • Published on 5/1/2017

    Meier CR, Jick SS. Antenatal Exposure and Diseases in the Offspring: The Role of Big Data. Drug Saf. 2017 May; 40(5):363-364. PMID: 28185070.

    Read at: PubMed
  • Published on 5/1/2017

    Li L, Neogi T, Jick S. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink. Rheumatology (Oxford). 2017 May 01; 56(5):753-762. PMID: 28077689.

    Read at: PubMed
  • Published on 2/12/2017

    Frey N, Jossi J, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. J Invest Dermatol. 2017 Jun; 137(6):1240-1247. PMID: 28202399.

    Read at: PubMed
  • Published on 2/10/2017

    Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS. Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia. Clin Epidemiol. 2017; 9:83-91. PMID: 28228662.

    Read at: PubMed
  • Published on 2/9/2017

    Frey N, Hügle T, Jick SS, Meier CR, Spoendlin J. Hyperlipidaemia and incident osteoarthritis of the hand: a population-based case-control study. Osteoarthritis Cartilage. 2017 Jul; 25(7):1040-1045. PMID: 28189828.

    Read at: PubMed
  • Published on 1/10/2017

    Seliger C, Meier CR, Becker C, Jick SS, Proescholdt M, Bogdahn U, Hau P, Leitzmann MF. Metabolic syndrome in relation to risk of meningioma. Oncotarget. 2017 Jan 10; 8(2):2284-2292. PMID: 27903988.

    Read at: PubMed
  • Published on 12/1/2016

    Spoendlin J, Layton JB, Mundkur M, Meier C, Jick SS, Meier CR. The Risk of Achilles or Biceps Tendon Rupture in New Statin Users: A Propensity Score-Matched Sequential Cohort Study. Drug Saf. 2016 Dec; 39(12):1229-1237. PMID: 27677637.

    Read at: PubMed

View 244 more publications:View full profile at BUMC

News & In the Media